Skip to main content
Clinical Trials/NCT07652099
NCT07652099Not yet recruitingNot Applicable

Cost-utility Analysis of the Use of a Laser Fiber in the Management of Non-abscessed Pilonidal Cyst

Elsan2 sites in 1 country150 target enrollmentStarted: June 15, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
150
Locations
2
Primary Endpoint
Incremental cost-utility ratio (ICUR) of laser fiber versus conventional surgery

Study Overview

Brief Summary

This multicenter, prospective, randomized, open-label trial compares laser fiber treatment with conventional surgery in adults with non-abscessed pilonidal cyst. The main objective is to evaluate the incremental cost-utility ratio of laser fiber versus conventional surgery over 12 months from a societal perspective. Secondary objectives include 3-month cost-utility, healing time, closure at 3 months, recurrence at 12 months, postoperative complications, treatment parameters, postoperative pain, and duration of sick leave.

Detailed Description

Pilonidal cyst surgery is common in France and mainly affects young adults. Conventional surgery is effective but may be associated with longer healing time, prolonged dressing use, and work absence. Laser fiber treatment is a minimally invasive alternative used in France since 2019 and may reduce healing time and postoperative burden; however, prospective randomized comparative medico-economic evidence is lacking. This national multicenter study randomizes adults with non-abscessed pilonidal cyst to laser fiber treatment or conventional surgery in a 1:1 ratio. The primary endpoint is the incremental cost-utility ratio over 12 months, using total costs and utility derived from EQ-5D-5L (QALY). Participants are followed from baseline to month 12, with assessments at J8, J15, M3, M6, M9, and M12.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 79 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female aged 18 years or older and younger than 80 years.
  • Patient for whom excision of a non-abscessed pilonidal cyst by laser fiber or conventional surgery is indicated.
  • Patient informed and having provided free, informed, written consent before any study-specific procedure.

Exclusion Criteria

  • Acute abscess.
  • Contraindication to surgery and/or anesthesia.
  • Need for urgent intervention for non-abscessed pilonidal cyst.
  • Participation in another ongoing study or exclusion period.
  • No health insurance coverage/protection.
  • Legal protection measure or deprived of liberty by judicial or administrative decision.
  • Hospitalized without consent.

Arms & Interventions

Laser fiber

Experimental

Laser fiber introduced through the cyst tract to destroy the cyst walls by thermal effect/burning; performed under general anesthesia with a small dry dressing afterwards.

Intervention: Laser fiber treatment (Procedure)

Conventional surgery

Active Comparator

Complete excision of the cystic area by incision around the entire contour of the cyst, followed by placement of packing and an absorbent dressing; performed under general anesthesia.

Intervention: Conventional surgery (Procedure)

Outcomes

Primary Outcomes

Incremental cost-utility ratio (ICUR) of laser fiber versus conventional surgery

Time Frame: 12 months after intervention

Calculated from total 12-month costs (direct medical, direct non-medical, indirect costs, including recurrences) and utility gain derived from EQ-5D-5L / QALY.

Secondary Outcomes

  • Incremental cost-utility ratio at 3 months(3 months after intervention)
  • Healing duration(Up to 12 months after intervention)
  • Closure of non-abscessed pilonidal cyst(3 months after intervention)
  • Recurrence of non-abscessed pilonidal cyst(12 months after intervention)
  • Postoperative complications(Short term: intervention to day 15; medium term: day 15 to month 3; long term: month 6 to month 12)
  • Treatment parameters(At day 0 intervention)
  • Postoperative pain evolution(Baseline to 12 months after intervention Pain measured at J0, J8, J15, M3, M6, M9, M12.)
  • Duration of sick leave(Up to 12 months after intervention)

Investigators

Sponsor
Elsan
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials